Access to treatment with buprenorphine was extended significantly with the passage of The Comprehensive Addiction and Recovery Act of 2016 (CARA) by the House and Senate this month with overwhelming margins. AAFP President Wanda Filer, M.D., M.P.H., of York, Pa., was pleased with the news saying that CARA “will expand much-needed access to care for Americans struggling with substance abuse disorders — a policy long-supported by the American Academy of Family Physicians and our members.” The bill addresses multiple aspects of treatment and funding for addiction-related issues. Read more HERE.
The American Society of Addiction Medicine greeted the passage through the legislature positively. Read more from ASAM HERE.
Read the bill HERE.